Rite Aid is also reserving shelf space with “Coming Soon” placeholders for all three SKUs -- VAZALORE 81 mg, 12 count; VAZALORE 81 mg, 30 count; and VAZALORE 325 mg, 30 count – to alert consumers about the new aspirin therapy that will soon be available.
“Our commercial launch plans are well under way, and we are delighted that Rite Aid is preparing its stores for VAZALORE later this summer. We look forward to adding Rite Aid to the growing number of retail pharmacy leaders that are providing access to this innovative aspirin therapy,” stated
About VAZALORE
VAZALORE is an FDA-approved liquid-filled aspirin capsule that provides patients with vascular disease and diabetic patients who are candidates for aspirin therapy based on physician recommendation, with fast, reliable and predictable platelet inhibition as compared to enteric-coated aspirin. It also reduces the risk of stomach erosions and ulcers, as compared to immediate-release aspirin, common in an acute setting. To learn more about VAZALORE, please visit www.vazalore.com.
About PLx Pharma Inc.
To learn more about PLx Pharma Inc. and its pipeline, please visit www.plxpharma.com.
Contact
Investor Relations:
T: 212-452-2793
E: lwilson@insitecony.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/63eb4491-f9b7-4c20-9a6b-5cf48bc22c80
VAZALORE
PLx Pharma Inc.’s VAZALORE to Launch in over 2,400 Rite Aid Stores in August.
2021 GlobeNewswire, Inc., source